References
- Rosenberg SA. Classification of lymphoid neoplasms. Blood 1994;84:1359–60.
- Gall EA, Mallory TB. Malignant lymphoma. A clinico-pathological survey of 618 cases. Am J Pathol 1942;18:381–429.
- Rosenberg SA, Berard CW, Brown BW, Dorfmann RF, Glastein E, Hoppe RT, et al.. National Cancer Institute sponsored study of classification of non Hodgkin’s lymphoma: summary and description of Working Formulation for clinical usage. The non Hodgkin’s lymphoma classification project. Cancer 1982;49:2112–35.
- Harris NL, Jaffes ES, Stein H, Banks PM, Chan JK, Cleary ML, et al.. A revised European American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361–92.
- Pittaluga S, Bijnens L, Teodorovic I, Hagenbeek A, Meerwaldt JH, Somer R, et al.. Clinical analysis of 670 cases in two trials of the European Organisation for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European American Classification of Lymphoid Neoplasms: a comparison with Working Formulation. Blood 1996;87:4358–67.
- Naresh KN, Sriniwas V, Soman CS. Distribution of various subtypes of non Hodgkin’s lymphoma in India: a study of 2773 lymphoma using REAL and WHO classification. Ann Oncol 2000;11:63–7.
- Sweetenham JW, Smartt PF, Wilkins BS, Pellatt JC, Smith JL, Ramsay A, et al.. The clinical utility of the Revised European-American Lymphoma (R.E.A.L.) Classification: preliminary results of a prospective study in patients with non-Hodgkin’s lymphoma from a single centre. Ann Oncol 1999;10:1121–4.
- Sheehan WW, Rappaport H. Morphological criteria in the classification of the malignant lymphomas. Proc Natl Cancer Conf 1970;6:59–71.
- Lukes RJ, Collins RD. Immunological characterization of human malignant lymphomas. Cancer 1974;34:1488–503.
- Lennert K, Mohri N, Stein H, Kaiserling E. The histopathology of malignant lymphoma. Br J Haematol (Suppl) 1975;31:193–203.
- Lennert K. Non-Hodgkin’s lymphoma: principles and application of the Kiel’s classification. Verh Dtsch Ges Pathol 1992;76:1–13.
- Portlock CS, Rosenberg SA. No initial therapy for stage III and IV non-Hodgkin’s lymphoma of favourable histologic types. Ann Intern Med 1979;90:10–3.
- Iskidogan A, Ayyildiz O, Buyukcelik A, Arslan A, Tiftik N, Buyukbayram H, et al.. Non-Hodgkin’s lymphoma in east Turkey: clinico-pathologic features of 490 cases. Ann Haematol 2004;83:265–9.
- Intragumtornchai T, Wannakrairoj P, Chaimongkol B, Bhoopat L, Lekhakula A, Thamprasit T, et al.. Non-Hodgkin’s lymphoma in Thailand: a retrospective pathologic and clinical analysis of 391 cases. Cancer 1996;78:1813–9.
- Kalyan K, Basu D, Soundararaghavan J. Immunohistochemical typing of non-Hodgkin’s lymphoma-comparing working formulation and WHO classification. Indian J Pathol Microbiol 2006;49:203–7.